STOCK TITAN

Regeneron officer McCourt proposes $545K share sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Regeneron Pharmaceuticals, Inc. (REGN) officer Marion McCourt reported a proposed sale of 566 common shares, with an aggregate market value of $545,239.12 and an approximate sale date of November 16, 2026. The shares were acquired through RSA vesting on December 12, 2023.

The notice lists February 17, 2026 as the plan adoption or instruction date in the Rule 10b5-1 section.

Proposed sale 566 common shares Approximate sale date November 16, 2026
Aggregate market value $545,239.12 For the 566 common shares proposed for sale
Common shares outstanding 101,630,713 shares Number shown in the notice
Prior sale on September 2, 2026 1,215 common shares Gross proceeds were $1,032,750.00
Prior sale on September 3, 2026 1,131 common shares Gross proceeds were $969,708.09
Prior sale on October 30, 2026 1,132 common shares Gross proceeds were $984,194.76
RSA Vesting financial
"The shares were acquired through RSA vesting"
Rule 10b5-1 regulatory
"plan adoption or instruction date in the Rule 10b5-1 section"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many REGN shares did Marion McCourt report for sale?

Officer Marion McCourt reported a proposed sale of 566 common shares, with an aggregate market value of $545,239.12 and an approximate sale date of November 16, 2026.

What were Marion McCourt's recent REGN stock sales?

The notice lists sales of 1,215 common shares for gross proceeds of $1,032,750.00 on September 2, 2026; 1,131 common shares for $969,708.09 on September 3, 2026; and 1,132 common shares for $984,194.76 on October 30, 2026.

What Rule 10b5-1 date does REGN's notice report?

It lists February 17, 2026 as the plan adoption or instruction date in the Rule 10b5-1 section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading